Dr. Lin is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
3032 Communications Pkwy
Plano, TX 75093Phone+1 972-943-8440Fax+1 972-943-8348
Education & Training
- Baylor College of MedicineFellowship, Gastroenterology, 2016 - 2019
- Stanford Health Care-Sponsored Stanford UniversityResidency, Internal Medicine, 2013 - 2016
- Baylor College of MedicineClass of 2013
Certifications & Licensure
- CA State Medical License 2014 - Present
- TX State Medical License 2023 - 2026
- WA State Medical License 2019 - 2024
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Gastroenterology
Publications & Presentations
PubMed
- Letter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers. Authors' ...Derek Lin, Hwai I. Yang, Joseph Hoang, Mindie H. Nguyen
Alimentary Pharmacology & Therapeutics. 2017-01-01 - 1 citationsLetter: should anti-viral therapy be recommended for individuals chronically infected with hepatitis B virus and at low risk of hepatocellular carcinoma? Authors' reply.Derek Lin, Hwai I. Yang, Joseph Hoang, Mindie H. Nguyen
Alimentary Pharmacology & Therapeutics. 2017-01-01 - 1 citationsLetter: reduction in chronic hepatitis B-related hepatocellular carcinoma with anti-viral therapy, including low-risk patients - more questions than answers.T.-Y. Wei, Chia-Chi Wang
Alimentary Pharmacology & Therapeutics. 2017-01-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: